Appeals court lifts halt on generic Entresto launch: report (NVS:NYSE)

A U.S. appeals court has lifted a temporary halt it imposed on the launch of a generic version of Novartis’s (NYSE:NVS) top-selling cardiac drug Entresto.

The U.S. Court of Appeals for the District of Columbia Circuit lifted the halt, which it had